FreeCME

Changing Paradigms in the Diagnosis and Treatment of Multiple Myeloma

These webcasts are co-provided by the CancerNet and A. Webb Roberts Center for CME of Baylor Scott & White Health.

For more information visit: www.cancernetus.com

Amgen, Inc.

These webcasts are intended to improve care of patients with multiple myeloma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussions of novel agents at various stages of clinical development will be given significant focus. These Internet CME activities are designed to provide clinical decision-making strategies for integration of novel therapeutic options.

Each module offers:

  • 1.25 to 1.5 AMA PRA Category 1 Credits™  for physicians, per module

 

 

Module 1

This webcast is intended to improve care of patients with multiple myeloma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

 

Module 2

This webcast is intended to improve care of patients with multiple myeloma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

 

Module 3

This webcast is intended to improve care of patients with multiple myeloma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.